About Metropolitan Hospital; Hematology Dept
Clinical Trials at Metropolitan Hospital; Hematology Dept
During the past decade, Metropolitan Hospital; Hematology Dept conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Metropolitan Hospital; Hematology Dept
According to Clinical.Site data, the most researched conditions in "Metropolitan Hospital; Hematology Dept" are
"Lymphocytic Leukemia, Chronic" (1 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "Metropolitan Hospital; Hematology Dept" in a lesser frequency.
Clinical Trials Intervention Types at Metropolitan Hospital; Hematology Dept
Most popular intervention types in "Metropolitan Hospital; Hematology Dept" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "CHOP" (1 trials), "Rituximab" (1 trials) and "rituximab [MabThera/Rituxan]" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Metropolitan Hospital; Hematology Dept
The vast majority of trials in "Metropolitan Hospital; Hematology Dept" are
2 trials for "All" genders.
Clinical Trials Status at Metropolitan Hospital; Hematology Dept
Currently, there are NaN active trials in "Metropolitan Hospital; Hematology Dept".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Metropolitan Hospital; Hematology Dept,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Metropolitan Hospital; Hematology Dept, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".